Metacrine Inc (MTCR)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Preston S. Klassen
Employees:
30
3985 SORRENTO VALLEY BLVD., SUITE C, SAN DIEGO, CA 92121
858-369-7800

Metacrine, Inc. focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis.

Data derived from most recent annual or quarterly report
Market Cap 21.072 Million Shares Outstanding42.57 Million Avg 30-day Volume 513.768 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.13
Price to Revenue0.0 Debt to Equity0.289 EBITDA-59.015 Million
Price to Book Value0.5576 Operating Margin0.0 Enterprise Value-23.362 Million
Current Ratio12.194 EPS Growth-0.55 Quick Ratio11.454
1 Yr BETA 0.7231 52-week High/Low 0.68 / 0.3 Profit Margin0.0
Operating Cash Flow Growth-22.3988 Altman Z-Score-5.2156 Free Cash Flow to Firm -36.876 Million
View SEC Filings from MTCR instead.

View recent insider trading info

Metacrine Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding MTCR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MTCR

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-03-24 by KLASSEN PRESTON
  • 4: filed on 2023-01-27 by YORK MICHAEL
  • 4: filed on 2022-12-21 by LEONARD BRADEN MICHAEL
  • 4: filed on 2022-11-09 by LEONARD BRADEN MICHAEL
  • 4: filed on 2022-10-31 by LEONARD BRADEN MICHAEL
  • 4: filed on 2022-10-26 by LEONARD BRADEN MICHAEL
  • 3: filed on 2022-10-26 by LEONARD BRADEN MICHAEL
  • 4: filed on 2022-09-06 by NASHAT AMIR
  • 4: filed on 2022-09-06 by JONKER JEFFREY DAVID
  • 4: filed on 2022-09-06 by MCHUTCHISON JOHN G

    • Events (8k)

  • 8-K: filed on 2023-03-24:
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-03-23:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-03-15:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
  • 8-K: filed on 2023-03-03:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-02-09:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
  • 8-K: filed on 2023-02-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-02-01:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-01-24:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-23:
    Item 1.02: Termination of a Material Definitive Agreement
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-11:
    Item 8.01: Other Events

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    KLASSEN PRESTON

    • Director
    		 1,384,116 2023-03-23 2

    YORK MICHAEL CHIEF BUSINESS OFFICER

    • Officer
    		 103,499 2023-01-26 1

    LEONARD BRADEN MICHAEL

    • 10% Owner
    		 12,750,919 2022-12-19 5

    GUGGENHIME ANDREW

    • Director
    		 16,500 2022-05-18 0

    NASHAT AMIR

    • Director
    • 10% Owner
    		 16,500 2022-05-18 0

    HEYMAN RICHARD A.

    • Director
    		 16,500 2022-05-18 0

    JONKER JEFFREY DAVID

    • Director
    		 16,500 2022-05-18 0

    MCHUTCHISON JOHN G

    • Director
    		 16,500 2022-05-18 0

    OWENS JULIA C.

    • Director
    		 16,500 2022-05-18 0

    EVANS RONALD M

    • Director
    		 16,500 2022-05-18 0

    SANDELL SCOTT D

    • 10% Owner
    		 2,563,257 2021-12-10 0

    BASKETT FOREST

    • 10% Owner
    		 2,563,257 2021-12-10 0

    WALKER PAUL EDWARD

    • 10% Owner
    		 2,563,257 2021-12-10 0

    SONSINI PETER W.

    • 10% Owner
    		 2,563,257 2021-12-10 0

    FLORENCE ANTHONY A. JR.

    • 10% Owner
    		 2,563,257 2021-12-10 0

    BEHBAHANI ALI

    • 10% Owner
    		 2,563,257 2021-12-10 0

    MAKHZOUMI MOHAMAD

    • 10% Owner
    		 2,563,257 2021-12-10 0

    NEW ENTERPRISE ASSOCIATES 16, L.P.

    NEA PARTNERS 16, L.P.

    NEA 16 GP, LLC

    • 10% Owner
    		 2,563,257 2021-12-10 0

    CHANG CARMEN

    • 10% Owner
    		 2,563,257 2021-12-10 0

    VENBIO GLOBAL STRATEGIC FUND, L.P.

    VENBIO GLOBAL STRATEGIC GP, L.P.

    VENBIO GLOBAL STRATEGIC GP, LTD.

    GOODMAN COREY S

    ADELMAN ROBERT J

    • 10% Owner
    		 2,443,421 2021-10-22 0

    BUROW KRISTINA

    • Director
    		 16,500 2021-05-24 0

    CHEN HUBERT C CHIEF MEDICAL OFFICER

    • Officer
    		 3,289 2021-05-20 0

    MILLICAN TRISHA CHIEF FINANCIAL OFFICER

    • Officer
    		 109,040 2021-05-05 0

    LEE CATHERINE CHAI-ZON EVP, GEN. COUNSEL & SECRETARY

    • Officer
    		 3,846 2021-05-05 0

    ARCH VENTURE FUND VIII, L.P.

    ARCH VENTURE FUND VIII OVERAGE, L.P.

    CRANDELL KEITH

    BYBEE CLINTON

    NELSEN ROBERT

    ARCH VENTURE PARTNERS VIII, LLC

    ARCH VENTURE PARTNERS VIII, L.P.

    • 10% Owner
    		 2,940,503 2020-09-18 0

    MAKOWER JOSHUA

    • 10% Owner
    		 3,060,527 2020-09-18 0

    VENBIO GLOBAL STRATEGIC FUND, L.P.

    VENBIO GLOBAL STRATEGIC GP, L.P.

    VENBIO GLOBAL STRATEGIC GP, LTD.

    GOODMAN COREY S

    • 10% Owner
    • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
    		 3,059,123 2020-09-18 0

    ADELMAN ROBERT J

    • Director
    • 10% Owner
    		 3,059,123 2020-09-18 0

    POLARIS MANAGEMENT CO. VII, L.L.C.

    POLARIS ENTREPRENEURS' FUND VII, L.P.

    POLARIS PARTNERS VII, L.P.

    • 10% Owner
    		 7,978,075 2020-09-18 0

    ALEXANDRIA VENTURE INVESTMENTS, LLC

    • 10% Owner
    		 No longer subject to file 2020-09-18 0

    GALLAGHER CAROL GILTNER

    • Director
    		 0 2020-09-15 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    METACRINE INC MTCR 2023-06-07 12:45:04 UTC -1.3433 6.4133 3600000
    METACRINE INC MTCR 2023-06-06 22:15:03 UTC -1.3433 6.4133 3600000
    METACRINE INC MTCR 2023-06-06 21:45:05 UTC -1.3433 6.4133 3600000
    METACRINE INC MTCR 2023-06-06 21:15:04 UTC -1.3433 6.4133 3600000
    METACRINE INC MTCR 2023-06-06 20:45:04 UTC -1.3433 6.4133 3600000
    METACRINE INC MTCR 2023-06-06 20:15:04 UTC -1.3433 6.4133 3600000
    METACRINE INC MTCR 2023-06-06 19:45:04 UTC -1.3433 6.4133 3600000
    METACRINE INC MTCR 2023-06-06 19:15:03 UTC -1.3433 6.4133 3600000
    METACRINE INC MTCR 2023-06-06 18:45:04 UTC -1.3433 6.4133 3600000
    METACRINE INC MTCR 2023-06-06 18:15:04 UTC -1.3433 6.4133 3600000
    METACRINE INC MTCR 2023-06-06 17:45:04 UTC -1.3433 6.4133 3600000
    METACRINE INC MTCR 2023-06-06 17:15:04 UTC -1.3433 6.4133 3600000
    METACRINE INC MTCR 2023-06-06 16:45:04 UTC -1.3533 6.4133 3600000
    METACRINE INC MTCR 2023-06-06 16:15:03 UTC -1.3533 6.4133 3600000
    METACRINE INC MTCR 2023-06-06 15:45:04 UTC -1.3533 6.4133 3600000
    METACRINE INC MTCR 2023-06-06 15:15:04 UTC -1.3533 6.4133 3600000
    METACRINE INC MTCR 2023-06-06 14:45:04 UTC -2.1738 7.2338 3600000
    METACRINE INC MTCR 2023-06-06 14:15:03 UTC -2.1738 7.2338 3600000
    METACRINE INC MTCR 2023-06-06 13:45:03 UTC -2.1738 7.2338 3600000
    METACRINE INC MTCR 2023-06-06 13:15:03 UTC -2.1738 7.2338 3600000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments